Tempus Presentation at the 2024 ASCO® Annual Meeting - Tempus

06/01/2024

Tempus Presentation at the 2024 ASCO® Annual Meeting

Transforming Precision Medicine: AI and Molecular Insights Intersect Across the Cancer Care Continuum

Speakers Ezra Cohen, MD, FASCO
Chief Medical Officer of Oncology, Tempus

Kate Sasser, PhD
Chief Scientific Officer, Tempus

Halla Nimeiri, MD
Chief Development Officer, Tempus

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

Related Content

View more

06/25/2024

Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health

Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more
04/15/2024

Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus

Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more
04/15/2024

Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next

Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more